A detailed history of Johnson & Johnson transactions in Nanobiotix S.A. stock. As of the latest transaction made, Johnson & Johnson holds 5,623,816 shares of NBTX stock, worth $22.7 Million. This represents 10.31% of its overall portfolio holdings.

Number of Shares
5,623,816
Previous 5,623,816 -0.0%
Holding current value
$22.7 Million
Previous $28.1 Million 15.0%
% of portfolio
10.31%
Previous 9.71%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$6.12 - $8.13 $28.5 Million - $37.9 Million
4,664,179 Added 486.04%
5,623,816 $36.6 Million
Q3 2023

Nov 09, 2023

BUY
$5.03 - $10.76 $4.83 Million - $10.3 Million
959,637 New
959,637 $8.4 Million

Others Institutions Holding NBTX

About Nanobiotix S.A.


  • Ticker NBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,875,900
  • Market Cap $141M
  • Description
  • Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cance...
More about NBTX
Track This Portfolio

Track Johnson & Johnson Portfolio

Follow Johnson & Johnson and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson & Johnson, based on Form 13F filings with the SEC.

News

Stay updated on Johnson & Johnson with notifications on news.